VBI Vaccines Inc. (VBIVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Inactive · Last trade price on Jan 13, 2025

VBI Vaccines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-82.99-92.84-113.3-69.75-46.23-54.81
Depreciation & Amortization
1.981.992.061.841.651.2
Other Amortization
1.891.881.7131.571
Asset Writedown & Restructuring Costs
24.624.6---6.29
Stock-Based Compensation
5.236.669.79.635.293.94
Other Operating Activities
7.479.6930.16-0.320.810.3
Change in Accounts Receivable
0.050.1-0.090.070.13-0.14
Change in Inventory
-5.34-3.72-5.69-0.51-1.95-0.39
Change in Accounts Payable
-0.94-6.658.890.362.06-5.18
Change in Unearned Revenue
6.116.360.02-0.33-0.77-1.69
Change in Other Net Operating Assets
-9.05-8.95-7.1516.12-9.610.76
Operating Cash Flow
-51-60.88-73.7-39.91-47.05-48.71
Capital Expenditures
-0.48-0.87-4.34-2-1-3.67
Investment in Securities
---25.15-25-
Investing Cash Flow
-0.48-0.87-4.3423.16-26-3.67
Long-Term Debt Issued
--201220-
Total Debt Issued
--201220-
Long-Term Debt Repaid
-----15.3-
Total Debt Repaid
-----15.3-
Net Debt Issued (Repaid)
--20124.7-
Issuance of Common Stock
25.1424.270.0133.38124.3340.25
Other Financing Activities
-1.6-1.58-0.56-1.09-6.63-2.84
Financing Cash Flow
23.5422.719.4544.29122.3937.42
Foreign Exchange Rate Adjustments
0.140.11-0.480.330.27-0.09
Net Cash Flow
-27.8-38.94-59.0727.8749.61-15.06
Free Cash Flow
-51.48-61.75-78.04-41.9-48.05-52.39
Free Cash Flow Margin
-547.03%-711.24%-7212.48%-6640.73%-4528.75%-2358.62%
Free Cash Flow Per Share
-2.63-3.97-9.07-4.93-6.60-13.16
Cash Interest Paid
6.266.133.232.041.612.03
Levered Free Cash Flow
-29.1-39.41-47.53-13.55-29.88-36.54
Unlevered Free Cash Flow
-25.89-36.25-45.97-13.36-29.38-35.65
Source: S&P Global Market Intelligence. Standard template. Financial Sources.